| Autor: |
Olorunsola, Emmanuel O., Abuh, Emem T., Etti, Imaobong C., Tologbonse, Adedoyin A. |
| Předmět: |
|
| Zdroj: |
Tropical Journal of Natural Product Research; Sep2024, Vol. 8 Issue 9, p8571-8576, 6p |
| Abstrakt: |
Haematological disorder is one of the manifestations in diabetes mellitus. This study aimed to investigate the effect of oral insulin-loaded Prosochit® nanoparticles on blood composition in diabetes. Twenty rats were selected from a community of alloxan-induced diabetic rats, divided into four equal groups and labelled Groups 1 to 4. Another group of 5 rats was kept without induction and without treatment as the healthy control group and labelled HCG. Group 1 animals were administered purified water (untreated), Group 2 was treated with oral insulin-loaded Prosochit® nanoparticles, Group 3 with oral unloaded Prosochit® nanoparticles and Group 4 with subcutaneous insulin - Actrapid® (positive control). The drug administration at the dose of 50 IU/kg was done daily for 28 days. Blood samples were taken and analyzed for glucose level on Days 0, 1 and 28. The samples were also subjected to complete blood count. After 24 h of commencing treatment, insulin-loaded Prosochit® nanoparticles limited the increase in the lymphocytes count to 4.08 x 109/L compared to the untreated group with the count of 6.23 x 109/L. It also brought forth a slight reduction in haemoglobin level to 11.5 g/L and maintained the number of platelets closest to the normal range. After 28 days, the lymphocytes count only increased to 4.56×109/L while that of the untreated diabetic group had increased to 8.92×109/L. The red blood cells and platelets counts were similar to those of the healthy rats. Oral insulin-loaded Prosochit® nanoparticles inhibits lymphocytosis in alloxan-induced diabetic rats. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
